Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Similar documents
Disclosures Rebecca T. Hahn, MD, FASE

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

How to assess ischaemic MR?

Quantification of MR

What are the best diagnostic tools to quantify aortic regurgitation?

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD

Guidelines in perspective?

Quantifying Aortic Regurgitation

Quantification of Aortic Regurgitation

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Primary Mitral Regurgitation

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

LUST trial. Echocardiography USER S MANUAL

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

The difficult patient with mitral regurgitation

Tricuspid and Pulmonary Valve Disease

Doppler Basic & Hemodynamic Calculations

Improvements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated

ECHOCARDIOGRAPHY DATA REPORT FORM

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Tricuspid and Pulmonary Valve Disease

MITRAL REGURGITATION ECHO PARAMETERS TOOL

NEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

Echocardiography: Guidelines for Valve Quantification

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

HEMODYNAMIC ASSESSMENT

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

25 different brand names >44 different models Sizes mm

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

Functional Mitral Regurgitation

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Advanced Applica,on of Point- of- Care Echocardiography in Cri,cal Care. Dr. Mark Tutschka Dr. Rob ArnAield

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

CHAPTER 5 EFFICIENT APPROACHES FOR QUANTIFICATION OF AORTIC REGURGITATION USING PROXIMAL ISOVELOCITY SURFACE AREA PROCESS

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

좌심실수축기능평가 Cardiac Function

Management of TR in Patients Undergoing Mitral Interventions

Goals of Reporting. Background of the STS/ACC TVT Registry. TVT Registry TAVR and MitraClip 10/11/ /11/2016 9:10 9:30 AM

Prosthetic valve dysfunction: stenosis or regurgitation

Introduction RECOMMENDATIONS

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning

HEART VALVE DISEASES. Dr. James Kadouch Medical Officer Cardiologist Delphine Labojka Method & Process Manager

TAVR: Echo Measurements Pre, Post And Intra Procedure

Stress Testing in Valvular Disease

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

Diastolic Heart Function: Applying the New Guidelines Case Studies

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

What echo measurements are key prior to MitraClip?

Asymptomatic Valvular Disease:

Quantitative Doppler echocardiography

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

Objectives. Considerations in management of multivalvular disease. Case Discussions. A Systematic Approach to Multivalve Disease.

Assessment of LV systolic function

SONOGRAPHER & NURSE LED VALVE CLINICS

Adel Hasanin Ahmed 1

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography

Aortic Regurgitation & Aorta Evaluation

Aortic stenosis with concomitant mitral regurgitation

Echocardiographic evaluation of mitral stenosis

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

AIMI-HF PROCEDURE MANUAL TECHNICAL GUIDE FOR ECHOCARDIOGRAPHY. MHI Core Laboratory E. O Meara - J.C. Tardif J. Vincent, G. Grenier, C.

Patient/prosthesis mismatch: how to evaluate and when to act?

RVOTO adult and post-op

Exercise-Induced Changes in Degenerative Mitral Regurgitation

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

British Society of Echocardiography

Back to Basics: Common Errors In Quantitation In Everyday Practice

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Pulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function. Irmina Gradus-Pizlo, MD

When Does 3D Echo Make A Difference?

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Transcription:

Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology

Valvular Regurgitation Valve regurgitation volume loads the ventricles Chronic volume loading may lead to ventricular dysfunction Irreversible ventricular dysfunction may precede the development of symptoms ie You may miss the boat if you wait for symptoms

Mitral Regurgitation Impact of pre-op LVEF N = 409 Enriquez-Serrano, Circulation 1994;90:830

Key Clinical Decisions Is the mitral regurgitation clinically significant? How severe? Is the patient symptomatic? Is ventricular function affected? If regurgitation is severe, but the patient is asymptomatic when is the right time for surgery? If regurgitation is not severe how do we monitor this in the future?

Optimal timing for surgery Hyperdynamic, dilating LV Normal EF, dilated LV Poor EF, dilated LV Disease Progression Reversible LV Dysfunction Irreversible LV Dysfunction Atrial Fibrillation, Pulm H/T Too Early Symptoms Too Late Time (Years)

When to operate? Risks Mortality < 1% Morbidity < 5% Failed repair? Improve Exercise Prevent LV failure Maintain NSR Benefits

Echo Assessment of Regurgitation Assessing the mechanism of regurgitation Determining the severity of regurgitation: qualitative and quantitative Assessing the hemodynamic consequences of regurgitation LV size and function, LA size, PA pressure

Echo Assessment of Regurgitation Assessing the mechanism of regurgitation Determining the severity of regurgitation: qualitative and quantitative Assessing the hemodynamic consequences of regurgitation LV size and function, LA size, PA pressure

Who Has The Most Regurgitation?

It s The Same Patient Low gain High scale Low scale High gain

Factors Which Affect Regurgitant Jet Size Instrumentation Doppler frequency, Nyquist limit, gain Eccentricity leading to jet distortion Haemodynamics driving pressure Chamber compliance

Valvular Regurgitation Severity of regurgitation is a key determinant of the load on the ventricle The size of the regurgitant orifice affects prognosis Enriquez-Serrano, NEJM 2005 352:875

Quantitative Measures Of Valve Regurgitation Vena Contracta Size 2d 3d Regurgitant Orifice Area PISA Volumetric Flow

Key Quantitative Parameters Regurgitant Volume the volume of blood which flow backwards through the leaky valve Regurgitation Fraction the percentage of the total stroke volume which flow backwards (Effective) Regurgitant Orifice Area the effective area of the leak RV = 40 ml RF = 40%

Quantitative Assessment Of The Mitral Valve

Vena Contracta Width Lancellotti, EHJ-CVI 2013 14:611

Vena Contracta Width Remains valid with eccentric jets Can be technically challenging Problematic with multiple jets?benefit with 3-D vena contracta

Vena Contracta by 3-D Yosefy Am J Card 2009 104:978

Proximal Isovelocity Surface Area Blood converges towards orifice. Doppler flow imaging reveals concentric hemispheric shells, representing isovelocity surfaces. As blood accelerates towards orifice, velocity aliasing occurs, and distinct red-blue interface occurs at shell boundary. The velocity is equal to the Nyquist limit. Adjust the Nyquist limit to optimise shell size. Calculate shell surface area = 2πr 2

Flow rate through any given shell equals flow rate through orifice (continuity equation). FR = aliasing velocity x 6.28 x r 2 (PISA). Flow rate = ERO x velocity jet Velocity jet obtained by CW. ERO effective regurg orifice area ERO = Flow rate velocity jet Regurg. vol. = ERO x TVI MR

Regurgitant orifice

Regurgitant volume

Limitations of PISA Method Irregular orifice shape may be helped by 3-D Flattening of the contours near the orifice. Loss of hemispheric shape. Constraint of flow by proximal structures. Affects ability to form hemisphere. Uncertainty in localising regurgitant orifice. An issue as you square the area in the PISA formula. Variability in regurgitant orifice through cardiac cycle. Multiple jets

Sources of Error with PISA Contour Flattening Near the Orifice Contour velocity: v a Orifice velocity: v 0 Conventional PISA Q = 2πr 2 v a Flow underestimated by v a /v 0 Ensure the hemisphere is large enough to minimize this

Sources of Error with PISA Proximal Flow Constraint by Surrounding Structures LA Flail Leaflet LA PFC LV LV Flail Leaflet Wall Constraint

Sources of Error with PISA Variable Orifice Size Lancellotti, EHJ-CVI 2013 14:611

Measurement of Mitral ROA Simplified PISA Formula LA 40 Assume LV-LA Δp is 100 mmhg Set aliasing velocity to 40 cm/sec Then ROA = r 2 /2 40 MV r = 8 mm LV ROA = 8 2 /2 = 32 mm 2

ROA by Simplified PISA Method: r 2 /2 r 2 /2 R=1.0cm ROA=0.5cm 2 Pu, Prior et al., JASE 2001 14:180

What Is Our Reference Method? Echo Studies Volumetric Flow MRI Studies Volumetric Flow

Quantitative Assessment of MR - Volumetric Flow Measure SV in 2 regions, one of which includes the regurgitant volume. Difference b/n these two SVs is the regurgitant volume through the valve. Area of the LVOT x VTI Mitral annular area x VTI Mitral annulus LVOT - Beware of AR Or LV stroke volume LVEDV-LVESV (3-d or Simpson s biplane) Regurg. flow rate (ml/s), fraction (%), orifice area.

Improving Accuracy & Usability Volumetric flow not often used Time-consuming Lancellotti, EHJ-CVI 2013 14:611

Simultaneous MV and LVOT flow - Real Time Colour Flow Doppler Thavendiranathan, JASE 2012 25:1

Simultaneous MV and LVOT flow Thavendiranathan, JASE 2012 25:1

RT-CFD More Accurate Than 2-D Problematic with both MR and AR present?use of RVOT Thavendiranathan, JASE 2012 25:1

Use All The Available Information Pulmonary vein flow Mitral inflow characteristics CW of the MR jet Signal intensity Shape of the signal

Systolic flow reversal in pulmonary veins

Mitral CW and PW Doppler MILD MOD SEVERE Lancellotti, EHJ-CVI 2010 11:307

Key Cut-off Values for MR Mild Moderate Severe Mod Mod Severe VC width < 0.3 0.3 0.69 0.7 R Vol (ml/beat) < 30 30-44 45-59 60 R Fract (%) < 30 30-39 40 49 50 EROA (cm 2 ) < 0.2 0.20 0.29 0.30 0.39 0.4 Zoghbi, JASE 2003 16:777

Aortic Regurgitation JET AREA AND JET LENGTH ARE NOT WELL CORRELATED WITH SEVERITY Quantification can be more difficult

Aortic Regurgitation JET AREA AND JET LENGTH ARE NOT WELL CORRELATED WITH SEVERITY Quantification can be more difficult

Use of PISA in Aortic Regurgitation Lancellotti, EHJ-CVI 2010 11:223

Use of PISA in Aortic Regurgitation Underestimation with tented valves Tribouilloy, JACC 1998 32:1032

Volumetric Flow in Aortic Regurgitation

Additional Parameters AR pressure half-time Diastolic flow reversal Upper descending aorta Abdominal aorta

AR and Pressure Half-time

Key Cut-off Values for AR Mild Moderate Severe Mod Mod Severe VC width < 0.3 0.3 0.60 0.6 R Vol (ml/beat) < 30 30-44 45-59 60 R Fract (%) < 30 30-39 40 49 50 EROA (cm 2 ) < 0.1 0.10 0.19 0.20 0.29 0.3 Zoghbi, JASE 2003 16:777

Tricuspid Regurgitation Many parallels with MR Vena contracta width can be used PISA can be used an EROA 40 mm 2 indicates severe TR R Vol > 45 ml suggests severe TR Other parameters suggesting severe TR systolic flow reversal in the hepatic veins V wave cut-off sign

ASE Guidelines for Native Valve Regurgitation 2003? Time for a new version Zoghbi, JASE 2003 16:777

EACVI Guidelines 2013 Estimation of the severity of valvular regurgitation: recommendations 1. The colour flow area of the regurgitant jet is not recommended to quantify the severity of valvular regurgitation. 2. Both VC measurement and the PISA method are recommended to evaluate the severity of regurgitation when feasible. 3. Adjunctive parameters should be used when there is discordance between the quantified degree of regurgitation and the clinical context. Lancellotti, EHJ-CVI 2013 14:611

Summary Accurate assessment of valvular regurgitation is important for clinical decision making Colour flow jet area is NOT recommended Quantitative measures are preferable PISA continues to be useful in selected cases Real-time 3D colour flow Doppler may become a method of choice for future quantification